CPBIO Holding Company Limited

As of June 30, 2026, CPBIO Holding Company Limited carries a market capitalization of 2.08B, placing it among publicly traded companies globally. Its enterprise value stands at 2.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, CPBIO Holding Company Limited has 240.72M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CPBIO Holding Company Limited maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 20, 2026, CPBIO Holding Company Limited's stock has declined approximately 2.75% over the past 52 weeks. The 50-day moving average sits at 8.45, while the 200-day moving average is 7.76.

As of June 30, 2026, CPBIO Holding Company Limited holds 292.12M in cash and equivalents against 592.62M in total debt, resulting in a net debt position of 298.14M. Total book value stands at 2.29B, with working capital of 757.98M providing operational flexibility.